Fred Alger Management »

Vyne Therapeutics shares owned by Fred Alger Management

Quarter-by-quarter ownership of Vyne Therapeutics (VYNE) shares owned by Fred Alger Management from 13F filings

Historical chart of Fred Alger Management investment in Vyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vyne Therapeutics held by Fred Alger Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vyne Therapeutics by Fred Alger Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $140k 60k 2.33

More positions owned by Fred Alger Management

Microsoft Corp Common (MSFT)
Nvidia Corp. Common (NVDA)
Amazon Common (AMZN)
Meta Platforms Inc Class A Common (META)
Apple Common (AAPL)
Natera Common (NTRA)
Alphabet Inc Cl C Common (GOOG)
Visa Inc Class A Shares Common (V)
Netflix Common (NFLX)
Advanced Micro Devices Common (AMD)
Broadcom Common (AVGO)
Taiwan Semiconductor Common (TSM)
Transdigm Group Common (TDG)
Eli Lilly & Co Common (LLY)
Vertiv Holdings Common (VRT)

View all positions for Fred Alger Management

Top funds holding Vyne Therapeutics

Cormorant Asset Management
Eventide Asset Management
Citadel Advisors
Parkman Healthcare Partners
DSC Advisors
Palo Alto Investors
AlphaCentric Advisors
Exome Asset Management
Schonfeld Strategic Advisors
Royal Bank of Canada
ADAR1 Capital Management
Geode Capital Management
Springbok Capital Management
Vanguard Group
Susquehanna International

View all funds holding Vyne Therapeutics